CRL vs TPGXL
Charles River Laboratories (CRL) versus TPG Operating Group II, L.P. 6.950% Fixed-Rate Junior Subordinated Notes due 2064 (TPGXL) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
TPG Operating Group II, L.P. 6.950% Fixed-Rate Junior Subordinated Notes due 2064 (TPGXL) common stock listed on NASDAQ.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. CRL currently screens at market cap $7.78B.
TPGXL does not have a complete income-statement cache yet.
CRL currently screens at market cap $7.78B. TPGXL currently screens at market cap $0.
Not investment advice. Open the CRL and TPGXL stock pages for the full models.
Not investment advice.